Product Information
Cinnarizine Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Description
Cinnarizine Tablets (15mg / 25mg / 75mg)
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
1. Product Introduction
Healthy Life Pharma Pvt. Ltd. is a specialized manufacturer of Cinnarizine Tablets in India. Cinnarizine is a piperazine antihistamine with calcium-channel-blocking properties and is used in various markets for motion sickness and selected vestibular disorders such as vertigo. We offer contract manufacturing services at our WHO-GMP compliant facility. Healthy Inc manages international export logistics and market-specific packaging requirements.
2. Product Specifications
| Parameter | Specification |
|---|
| Product Name | Cinnarizine Tablets |
|---|
| Generic Name | Cinnarizine Tablets BP / IP |
|---|
| CAS Number | 298-57-7 |
|---|
| Strength | 15mg / 25mg / 75mg |
|---|
| Dosage Form | Uncoated Tablet |
|---|
| Standard | BP / IP Compliant, as applicable |
|---|
| Therapeutic Class | Antihistamine (H1) / Vestibular Suppressant |
|---|
| Shelf Life | 36 Months, subject to validated stability data |
|---|
| Packaging | 10×10 Blister / 100s or 1000s Bottle / market-specific pack |
|---|
3. Manufacturing Technology
- Formulation & Dissolution: Because Cinnarizine has low aqueous solubility, API characteristics, excipient selection and manufacturing parameters are controlled according to the validated formulation to support consistent product performance.
- Higher-Strength Formulation: Compression and excipient parameters for higher-strength tablets are optimized to maintain tablet integrity, disintegration and acceptable size.
- Uniformity: Validated blending and in-process controls support consistent distribution of the active ingredient and dosage-unit quality.
- The Exporter: Healthy Inc. Retail and institutional packs can be supplied according to registration and destination-market requirements.
4. Quality Assurance
- Dissolution: Finished tablets are tested against the applicable registered or pharmacopoeial dissolution specification.
- Assay & Content Uniformity: Potency and dosage-unit uniformity are verified against approved specifications.
- Related Substances: Specified impurities and degradation products are monitored during release and stability testing.
5. Why Use Cinnarizine?
Cinnarizine has antihistaminic and vestibular-suppressant actions that can reduce motion-related nausea and selected symptoms of vestibular dysfunction.
Key Indications:
- Motion Sickness: Used in various markets for prevention and treatment of travel-related nausea and dizziness.
- Vertigo / Vestibular Disorders: May be used for selected vestibular symptoms according to local approved indications.
- Ménière’s-Related Symptoms: May be prescribed in some jurisdictions for dizziness, nausea and related vestibular symptoms.
- Other Uses: Vascular or other uses vary by jurisdiction and should follow approved prescribing information and clinician guidance.
6. Export and Regulatory Support
- Dossier Support: CTD and ACTD documentation where applicable.
- Certificates: FSC, COPP and COA where applicable.
- Logistics: Air or sea shipment via FOB Mumbai / CIF according to commercial and regulatory requirements.
7. Frequently Asked Questions
Q: Who manufactures Cinnarizine Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Cinnarizine Tablets in India.
Q: Is Cinnarizine sold under different brand names?
A: Yes. Cinnarizine is marketed under various brands internationally. Generic equivalence and interchangeability depend on the registered formulation and local regulatory requirements.
Q: When should Cinnarizine be taken for travel sickness?
A: Timing varies by product and market. Follow the approved product label or a healthcare professional’s instructions; many formulations are taken before travel begins.
Q: Does Cinnarizine cause sleepiness?
A: Yes. Drowsiness can occur, especially when treatment is started. Patients should avoid driving or operating machinery if affected.
Clinical Pharmacology & Safety Information
(For Registered Medical Practitioners & Patient Reference)
8. Dosage and Administration
- Motion Sickness: Dose and timing depend on age, formulation and the approved local product information.
- Vertigo / Vestibular Disorders: Treatment schedules should follow the approved product label and individual clinical assessment.
- Pediatric Use: Children require age-appropriate dosing and medical or label guidance; adult-strength tablets may not be suitable for all ages.
- Administration: Follow the prescribed schedule. Taking Cinnarizine after food may reduce gastric discomfort in some patients.
9. Side Effects and Precautions
- CNS: Drowsiness, fatigue or dizziness can occur. Alcohol and other sedating medicines may increase these effects.
- Extrapyramidal / Parkinsonian Effects: Prolonged use, particularly in older adults, has been associated with parkinsonism and other movement disorders. New tremor, rigidity or movement changes require medical review.
- Parkinson’s Disease: Cinnarizine may worsen parkinsonian symptoms and should be used only after careful medical assessment where relevant.
- Other Effects: Gastrointestinal discomfort and weight gain may occur in some patients.
10. Storage Instructions
- Store below 25°C in a dry place.
- Protect from excessive moisture and heat.
- Keep the container tightly closed where supplied in bottles.
- Keep out of reach of children.
